Mobile

The purpose of this study is to evaluate if F/R/TAF works as well as Atripla. It is also to see if F/R/TAF will maintain the control of your HIV-1 infection when compared to Atripla. Safety, how well ...

Update Il y a 4 ans
Reference: EUCTR2014-004779-21

The purpose of this study is to evaluate if F/R/TAF works as well as Atripla. It is also to see if F/R/TAF will maintain the control of your HIV-1 infection when compared to Atripla. Safety, how well your body accepts the drug, will be evaluated

Woman and Man

  • | Country :
    • -
  • | organs :
    • -
  • | Specialty :
    • -

Extract

To evaluate the non-inferiority of switching to the FTC/RPV/TAF FDC as compared to continuing EFV/FTC/TDF FDC in virologically suppressed HIV-1 infected subjects as determined by maintaining HIV-1 RNA < 50 copies/mL at Week 48 (FDA Snapshot Algorithm).

Inclusion criteria

  • Human Immunodeficiency Virus (HIV-1) Infection

Links